NAT-Bendamustine: Discoloration
· Published by Health Canada · Official notice
Alert type: Health product recall
Category: Health products - Drugs
Product: NAT-Bendamustine 100 mg/vial
Issue: Health products - Product quality
What to do: Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Audience: General public, Healthcare, Hospitals
Recall class: Type II
| Brand | Product Name | Market Authorization | Dosage Form | Lot number | Strength |
|---|
| Natco Pharma | Nat-Bendamustine | DIN 02496895 | Powder for Solution | 501902 | Bendamustine hydrochloride 100 mg/vial |
The colour is out of specification in the affected lot(s).